The Next Potential Alzheimer’s Drug Clears a Big Hurdle ...Middle East

Time - News
The Next Potential Alzheimer’s Drug Clears a Big Hurdle
After many years of slow progress, drug companies searching for the next big treatment for Alzheimer’s disease are finally starting to see the fruits of their labors. A panel of brain and Alzheimer’s experts convened by the U.S. Food and Drug Administration (FDA) voted unanimously on June 10 that a new Alzheimer’s drug developed by Eli Lilly, called donanemab, is effective and that the benefits of the medication outweigh its risks. The agency will now take the committee’s advice under consideration as it decides whether to approve the drug. [time-brightcove not-tgx=”true”] The FDA postponed its original decision on donanemab, which was scheduled for late last year, because it

Hence then, the article about the next potential alzheimer s drug clears a big hurdle was published today ( ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The Next Potential Alzheimer’s Drug Clears a Big Hurdle )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News